A ground staff walks past a container kept at the Cargo Terminal 2 of the Indira Gandhi International Airport, which according to the officials will be used as a COVID-19 vaccine handling and distribution center, during the media preview in New Delhi, India December 22, 2020. REUTERS/Anushree Fadnavis?
NEW DELHI (Reuters) - India is likely to approve Oxford/AstraZeneca's coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities, two sources with knowledge of the matter told Reuters on Tuesday.
This could be the first country to give the regulatory green light for the British drugmaker's vaccine as the British medicine regulator continues to examine data from the trials.
Limited time offer:
Just RM5 per month.
